Kelsey Tsai
Private Equity Investor bei 213 Management LLC
Profil
Kelsey Tsai is a Vice President for Sandbox Healthcare.
She supports the Blue Venture Fund’s investments in Thrive (now Exact Sciences), Onc.AI, Sempre Health, AbleTo and Workit Health.
Prior to Sandbox, Kelsey was an MBA associate at ARCH Venture Partners, as well as an Innovation Fund associate for the University of Chicago’s seed stage tech and life sciences fund.
Kelsey started her career as a biotech equity research analyst at Morningstar.
Kelsey holds an MBA from the University of Chicago Booth School of Business and a BA in Economics from Georgetown University.
She is also a CFA charterholder.
Aktive Positionen von Kelsey Tsai
Unternehmen | Position | Beginn |
---|---|---|
213 Management LLC
213 Management LLC Investment ManagersFinance 213 Management LLC (213 Management) is a venture capital firm founded in 2003 by Bob Shapiro and Nick Rosa. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 01.10.2021 |
Ausbildung von Kelsey Tsai
The University of Chicago Booth School of Business | Masters Business Admin |
Georgetown University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
213 Management LLC
213 Management LLC Investment ManagersFinance 213 Management LLC (213 Management) is a venture capital firm founded in 2003 by Bob Shapiro and Nick Rosa. The firm is headquartered in Chicago, Illinois. | Finance |